Literature DB >> 12515905

Evaluation of blood units with isolated anti HBC for the presence of HBV DNA.

Abdel-Rahman N Zekri1, Azza A Awlia, Hadeer El Mahalawi, Emad F Ismail, Gamal M Mabrouk.   

Abstract

We screened blood donors in one center in Saudi Arabia for a safety transfusion. We found that among 5043 blood donors negative for HCV and HIV, the incidence of HBsAg positivity was 2.97%. When antiHBc antibody was measured (HBcIg) in HBsAg negative donors, we observed that 21.47% were positive indicating previous exposure to hepatitis B virus. The HBcIg positive blood was further screened for HBsAb and the specimens were found to be reactive in 81.54%. Based on these data blood transfusion was permissible from donors who showed HBsAg negativity, HBcIg positive and HBsAb reactive blood. In order to ensure safety transfusion an aliquot of specimens (n = 80) was further analyzed for HBV DNA by PCR. We found only one specimen positive with incidence of 1.25%. So we recommended restricting transfusion from the previously mentioned donors to emergencies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12515905      PMCID: PMC3850589          DOI: 10.1155/2002/156359

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  3 in total

1.  Extraction of protoporphyrin disodium and its inhibitory effects on HBV-DNA.

Authors:  Chao-Pin Li; Li-Fa Xu; Qun-Hong Liu; Chao Zhang; Jian Wang; Yu-Xia Zhu
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers.

Authors:  Faisal Mousa Alzahrani; Saeed Sattar Shaikh; Amer Ibrahim Alomar; Sadananda Acharya; Nasreldin Elhadi
Journal:  Ann Lab Med       Date:  2019-01       Impact factor: 3.464

3.  Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.

Authors:  Gharib Karimi; Maryam Zadsar; Nasrin Vafaei; Zohreh Sharifi; Mohammad FalahTafti
Journal:  Virol J       Date:  2016-03-05       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.